Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Age per se should not be a contraindication to kidney transplantation. The first studies have shown a benefit for the survival of elderly eligible patients getting a kidney transplant compared to be maintained on the waiting list. However, more recent data suggest that this benefit is not as constant, notably with a significant early mortality period. In this retrospective single-center study we evaluated the short-term outcome after kidney transplant in recipients older than 65 years in terms of patient and graft survival and causes of death.
From 2014 to 2024, 123 consecutive transplanted recipients older than 65 years were included. Recipient characteristics were analyzed: sex, age, cause of CKD, duration of dialysis, time in waiting list. There were other parameters cold and warm ischemia times, number of mismatches, delayed graft function, biopsy-proven acute rejection, and causes of death and number of rejections in the first 3 months after transplantation. Induction immunosuppressive therapy was performed with basiliximab or thymoglobulin. Baseline triple immunosuppression included calcineurin inhibitor, antimetabolite, and steroids.
The median age was 68 years (interquartile range: 66–71), and the percentage of males was 54.4%. The main causes of chronic kidney disease (CKD) were chronic glomerulonephritis (29.3%), arterial hypertension (17.9%), and diabetes mellitus (13.8%). Overall mortality in the first three months was 27.6%. Causes of death included infections (87%), cardiovascular disease (10%), and cerebrovascular disease (3%). At three months, overall graft survival was 89%. A comparative analysis between the group of survivors and those who died within the first three months after transplantation indicated that the duration of dialysis was a statistically significant factor associated with an unfavorable outcome (p=0.001), while a greater number of mismatches (greater than 2) determined the risk of death (p=0.059).
In our single-center study, kidney transplantation in patients older than 65 years was feasible, with a total mortality rate of 27.6% at three months after the operation. Infection was the main cause of unfavorable outcomes. Additionally, the duration of dialysis before kidney transplantation was associated with patient mortality following the operation.
